The AJMC® Chronic Kidney Disease compendium is a comprehensive resource for clinical news and expert insights on the condition and treatment of loss of kidney function.
March 28th 2024
The FDA approved vadadustat (Vafseo), an oral medication, to treat anemia in adult patients with chronic kidney disease (CKD) on dialysis for at least 3 months. This fills a need for a new treatment option as anemia is common in these patients and can significantly impact their quality of life.
Higher Mortality Risk Linked to ESRD Requiring LVAD Implantation in New Study
May 8th 2022A study found that patients with end stage renal/kidney disease (ESRD) who undergo left ventricular assist device (LVAD) implantation had higher 1-year mortality compared with patients with chronic kidney disease.
Read More
Novel Internet-Based Hospital-to-Home Model for Nutritional Nursing Effective in Patients With CKD
April 23rd 2022Continual nutrition modification is crucial in patients with moderate to advanced chronic kidney disease (CKD), and more interactive at-home solutions hold potential to improve nutritional nursing models after hospital discharge.
Read More
Incremental Hemodialysis Provides Better Savings, Same Outcomes as Standard Hemodialysis
April 16th 2022Researchers found that implementing an incremental schedule for hemodialysis in patients with residual kidney disease produced similar clinical outcomes and significant savings for health systems compared with hemodialysis administered on a more traditional schedule.
Read More
Examining Changes in STEMI Treatment Strategies and Outcomes in CKD Over Time
April 9th 2022Despite underrepresentation in clinical trials of acute coronary syndrome treatments, a recent study suggests treatment strategies and outcomes in chronic kidney disease patients with ST-elevation myocardial infarctions (STEMI) have improved over time.
Read More
Several Factors Contribute to Impaired Fertility in Women, Men With CKD
April 8th 2022A literature review outlined the number of fertility complications that men and women with chronic kidney disease (CKD) face as well as the list of potential factors that can impact fertility and sexual functions in this population.
Read More
The risk-adjusted 1-year mortality rate was not different between Medicare Advantage and traditional Medicare beneficiaries with kidney failure who initiated dialysis.
Read More
Review Reveals Evidence Gaps in Managing Pruritus in Patients With CKD on Dialysis
March 30th 2022A literature review pointed out the limited current research that has been conducted on how to manage pruritus in patients with chronic kidney disease (CKD) treated with hemodialysis, suggesting that more data is needed to improve symptom burden in these patients.
Read More
Study Concludes Greater Focus Needed on MAFLD Due to CKD Risk Association
March 24th 2022Investigators confirmed an association between fatty liver disease related to metabolic dysfunction (MAFLD) and chronic kidney disease (CKD), and stressed a greater focus on treating MAFLD is needed to help manage risks.
Read More
Finerenone Reduces Heart Failure Risk in Patients With CKD, T2D
March 15th 2022Finerenone (Kerendia) was found to reduce risk of heart failure and improve other cardiovascular outcomes in patients with chronic kidney disease (CKD) and type 2 diabetes (T2D) regardless of heart failure history.
Read More
Dr Robert Gabbay Talks About Adding Finenerone as a Recommended Drug in New ADA Guidelines
February 24th 2022Robert Gabbay, MD, PhD, of the American Diabetes Association (ADA), breaks down the reasoning behind the organization's decision to add Bayer's Kerendia (finerenon) as a recommended drug for kidney disease prevention.
Read More
Improving Models to Boost Prediction of CVD Issues in Patients With CKD
February 10th 2022Adding risk factors specific to patients with chronic kidney disease (CKD) to risk prediction models for cardiovascular disease (CVD) could improve risk prediction capabilities for a population of patients often subject to invasive diagnostic procedures, investigators concluded.
Read More
Which Factors Sway Patient, Caregiver Decisions About CKD Research Participation?
February 7th 2022Patients with chronic kidney disease (CKD) and their caregivers who have participated in CKD research shared factors that may encourage or discourage others from enrolling in clinical studies, highlighting the ways that investigators can better involve patients in research.
Read More